↓ Skip to main content

Cochrane Database of Systematic Reviews

Antidepressants for smoking cessation

Overview of attention for article published in Cochrane database of systematic reviews, January 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
1 news outlet
blogs
2 blogs
policy
3 policy sources
twitter
34 tweeters
facebook
3 Facebook pages
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
306 Dimensions

Readers on

mendeley
447 Mendeley
Title
Antidepressants for smoking cessation
Published in
Cochrane database of systematic reviews, January 2014
DOI 10.1002/14651858.cd000031.pub4
Pubmed ID
Authors

John R Hughes, Lindsay F Stead, Jamie Hartmann-Boyce, Kate Cahill, Tim Lancaster

Abstract

There are at least three reasons to believe antidepressants might help in smoking cessation. Firstly, nicotine withdrawal may produce depressive symptoms or precipitate a major depressive episode and antidepressants may relieve these. Secondly, nicotine may have antidepressant effects that maintain smoking, and antidepressants may substitute for this effect. Finally, some antidepressants may have a specific effect on neural pathways (e.g. inhibiting monoamine oxidase) or receptors (e.g. blockade of nicotinic-cholinergic receptors) underlying nicotine addiction.

Twitter Demographics

The data shown below were collected from the profiles of 34 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 447 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 2 <1%
Netherlands 1 <1%
France 1 <1%
United Kingdom 1 <1%
Brazil 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 439 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 73 16%
Student > Bachelor 67 15%
Researcher 58 13%
Student > Ph. D. Student 53 12%
Student > Doctoral Student 38 9%
Other 81 18%
Unknown 77 17%
Readers by discipline Count As %
Medicine and Dentistry 153 34%
Psychology 53 12%
Nursing and Health Professions 29 6%
Pharmacology, Toxicology and Pharmaceutical Science 19 4%
Social Sciences 18 4%
Other 74 17%
Unknown 101 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 55. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 September 2021.
All research outputs
#584,705
of 21,196,061 outputs
Outputs from Cochrane database of systematic reviews
#1,239
of 12,078 outputs
Outputs of similar age
#7,508
of 303,407 outputs
Outputs of similar age from Cochrane database of systematic reviews
#13
of 153 outputs
Altmetric has tracked 21,196,061 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,078 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.8. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 303,407 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 153 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.